Multiple Sclerosis Clinical Trials in San Antonio

Showing 221-240 of 513 trials

A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

NCT03416816

This is a Phase 1, open label, multi-center study of orally administered DSP-0337 in adult subjects with advance solid tumors that are refractory to standard treatment, or for whom no effective therapy exists.

Neoplasms

Sumitomo Pharma America, Inc.23 participantsStarted May 2018

Indianapolis, Indiana, United States • Detroit, Michigan, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

This is a clinical trial studying the administration of NanoDoce as a direct injection to the bladder wall immediately after tumor resection and as an intravesical instillation. All participants will receive NanoDoce, and will be evaluated for safety and tolerability, as well as the potential effects of NanoDoce on urothelial carcinoma.

Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more

NanOlogy, LLC36 participantsStarted Apr 2019

Phoenix, Arizona, United States • Baltimore, Maryland, United States • New York, New York, United States +2 more locations

A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Multiple Sclerosis Trials in Other Cities

Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

The Canadian/US Integrative Oncology Study

International Lung Screen Trial (ILST)

Other Conditions in San Antonio